Education
About Us
Working with TipRanks
Follow Us
Vicore Pharma Holding AB (DE:6Y4)
FRANKFURT:6Y4
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 3.82M | kr 109.35M | kr 0.00 | kr 0.00 | kr 0.00 |
| Gross Profit | kr 0.00 | kr 109.35M | kr -3.42M | kr -3.61M | kr -3.60M |
| Operating Income | kr -454.44M | kr -194.19M | kr -321.51M | kr -290.73M | kr -294.82M |
| EBITDA | kr -454.44M | kr -166.64M | kr -317.47M | kr -286.20M | kr -289.82M |
| Net Income | kr -477.47M | kr -168.63M | kr -310.94M | kr -288.42M | kr -296.48M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 1.17B | kr 1.16B | kr 482.66M | kr 261.74M | kr 371.20M |
| Total Assets | kr 1.22B | kr 1.20B | kr 497.84M | kr 338.01M | kr 451.17M |
| Total Debt | kr 0.00 | kr 0.00 | kr 0.00 | kr 65.00K | kr 320.00K |
| Net Debt | kr -578.15M | kr -1.16B | kr -333.62M | kr -256.74M | kr -293.88M |
| Total Liabilities | kr 124.16M | kr 73.78M | kr 42.45M | kr 48.92M | kr 67.85M |
| Stockholders' Equity | kr 1.10B | kr 1.13B | kr 455.39M | kr 289.08M | kr 383.32M |
| Cash Flow | |||||
| Free Cash Flow | kr 0.00 | kr -164.95M | kr -448.62M | kr -302.92M | kr -265.17M |
| Operating Cash Flow | kr -374.44M | kr -164.95M | kr -249.58M | kr -299.92M | kr -265.17M |
| Investing Cash Flow | kr -601.81M | kr 149.04M | kr -144.46M | kr 74.00M | kr -7.00M |
| Financing Cash Flow | kr 430.54M | kr 834.06M | kr 470.86M | kr 187.04M | kr 318.18M |